New drug duo aims to stop aggressive breast Cancer's return
NCT ID NCT05973864
Summary
This study is for people with triple-negative breast cancer who still have cancer cells after initial chemo-immunotherapy and surgery. It tests if adding the pill capecitabine to the immunotherapy pembrolizumab after surgery is better at preventing the cancer from coming back than pembrolizumab alone. The main goal is to see if this combination helps patients live longer without their cancer returning.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRIPLE NEGATIVE BREAST NEOPLASMS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHD Vendee
RECRUITINGLa Roche-sur-Yon, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
CHU Amiens Picardie_Site Sud
RECRUITINGAmiens, 80054, France
Contact Email: •••••@•••••
Contact
-
CHU Bretonneau
RECRUITINGTours, 37000, France
Contact Email: •••••@•••••
Contact
-
CHU Jean Minoz
RECRUITINGBesançon, France
Contact Email: •••••@•••••
Contact
-
Centre François Baclesse
RECRUITINGCaen, 14000, France
Contact Email: •••••@•••••
Contact
-
Centre Georges-François Leclerc
RECRUITINGDijon, France
Contact Email: •••••@•••••
Contact
-
Centre Hospitalier de la Côte Basque
RECRUITINGBayonne, 64109, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Centre Léon Bérard
RECRUITINGLyon, 69008, France
Contact Email: •••••@•••••
Contact
-
Centre Oscar Lambret
RECRUITINGLille, France
Contact Email: •••••@•••••
Contact
-
Centre Paul Strauss
RECRUITINGStrasbourg, France
Contact Email: •••••@•••••
Contact
-
Clinique Mutualiste de l'Estuaire
RECRUITINGSaint-Nazaire, France
Contact Email: •••••@•••••
Contact
-
Clinique de La Croix du sud
RECRUITINGQuint-Fonsegrives, 31130, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Institut Claudius Regaud, IUCT Oncopole
RECRUITINGToulouse, France
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Institut Curie
RECRUITINGParis, 75005, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Institut Curie
RECRUITINGSaint-Cloud, 92210, France
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Institut Godinot
RECRUITINGReims, 51100, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Institut Paoli-Calmettes
RECRUITINGMarseille, 13009, France
Contact Email: •••••@•••••
Contact
-
Institut Sainte Catherine
RECRUITINGAvignon, 84918, France
Contact Email: •••••@•••••
Contact
-
Institut de Cancérologie de Lorraine
RECRUITINGVandœuvre-lès-Nancy, 54519, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Polyclinique Bordeaux Nord Aquitaine
RECRUITINGBordeaux, 33077, France
Contact Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.